Skip to main content
. 2021 Sep 2;17(6):2081–2106. doi: 10.1007/s12015-021-10246-3

Fig. 2.

Fig. 2

Recent developments of CAR NK cells to increase the efficacy and safety of cancer treatment. Created by Esmaeiladeh et al. CAR: chimeric antigen receptor, NK: natural killer cell, TAA: tumor-associated antigen, IL-4: interleukin-4, IL-7: interleukin-7, TGF-ΒRII: transforming growth factor beta receptor II, IL-15: interleukin-15, KIR: killer inhibitory receptor, iC9: inducible caspase 9, ICR: inverted cytokine receptor, SynNotch: synthetic Notch, scFv: single-chain variable fragment